Skip to main content
Clinical Trials/ACTRN12615001166561
ACTRN12615001166561
Completed
Phase 3

A randomised placebo controlled trial of the efficacy of carrageenan nasal spray in reducing asthma exacerbations, as measured by the asthma control questionnaire, when taken during a cold.

Julian Crane0 sites361 target enrollmentNovember 2, 2015

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Asthma exacerbation during a cold
Sponsor
Julian Crane
Enrollment
361
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 2, 2015
End Date
September 13, 2018
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Julian Crane

Eligibility Criteria

Inclusion Criteria

  • People who have ever been doctor diagnosed with asthma, and who have had at least one cold in the past 12 months with asthma symptoms.

Exclusion Criteria

  • Those with COPD (doctor diagnosed), those who plan to use a nasal spray for another condition during the study period, those whose asthma does not worsen with a cold, those who have a previous sensitivity or allergy to carrageenan or other seaweed products, a history of nasal polyps, or those with 'current unstable asthma' which we define as having been hospitalised for asthma within the last 2 months or use of oral corticosteroids in the past month.

Outcomes

Primary Outcomes

Not specified

Similar Trials